Literature DB >> 9453602

Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy.

A H Zea1, M T Ochoa, P Ghosh, D L Longo, W G Alvord, L Valderrama, R Falabella, L K Harvey, N Saravia, L H Moreno, A C Ochoa.   

Abstract

Advanced stages of mycobacterial diseases such as leprosy and tuberculosis are characterized by a loss of T-cell function. The basis of this T-cell dysfunction is not well understood. The present report demonstrates major alterations in the expression of signal transduction molecules in T cells of leprosy patients. These alterations were most frequently observed in lepromatous leprosy (LL) patients. Of 29 LL patients, 69% had decreased T-cell receptor zeta-chain expression, 48% had decreased p56(lck) tyrosine kinase, and 63% had a loss of nuclear transcription factor NF-kappaB p65. An electrophoretic mobility shift assay with the gamma interferon core promoter region revealed a loss of the Th1 DNA-binding pattern in LL patients. In contrast, tuberculoid leprosy patients had only minor signal transduction alterations. These novel findings might improve our understanding of the T-cell dysfunction observed in leprosy and other infectious diseases and consequently might lead to better immunologic evaluation of patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453602      PMCID: PMC107934     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene.

Authors:  H A Young; P Ghosh; J Ye; J Lederer; A Lichtman; J R Gerard; L Penix; C B Wilson; A J Melvin; M E McGurn
Journal:  J Immunol       Date:  1994-10-15       Impact factor: 5.422

2.  Familial defect of CD3 (T3) expression by T cells associated with rare gut epithelial cell autoantibodies.

Authors:  J R Regueiro; A Arnaiz-Villena; M Ortiz de Landázuri; J M Martín Villa; J L Vicario; V Pascual-Ruiz; F Guerra-Garcia; J Alcamí; M López-Botet; J Manzanares
Journal:  Lancet       Date:  1986-05-31       Impact factor: 79.321

Review 3.  Th1-Th2 paradigm: insights from leprosy.

Authors:  R L Modlin
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551

4.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

5.  T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.

Authors:  C Renner; S Ohnesorge; G Held; S Bauer; W Jung; J P Pfitzenmeier; M Pfreundschuh
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

6.  Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae.

Authors:  N Misra; A Murtaza; B Walker; N P Narayan; R S Misra; V Ramesh; S Singh; M J Colston; I Nath
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

7.  Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex.

Authors:  J J Sussman; J S Bonifacino; J Lippincott-Schwartz; A M Weissman; T Saito; R D Klausner; J D Ashwell
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

Review 8.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.

Authors:  T H Rea
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

9.  Learning from lesions: patterns of tissue inflammation in leprosy.

Authors:  R L Modlin; J Melancon-Kaplan; S M Young; C Pirmez; H Kino; J Convit; T H Rea; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.

Authors:  R L Modlin; H Kato; V Mehra; E E Nelson; X D Fan; T H Rea; P K Pattengale; B R Bloom
Journal:  Nature       Date:  1986 Jul 31-Aug 6       Impact factor: 49.962

View more
  27 in total

1.  Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico.

Authors:  María G Zavala-Cerna; Mary Fafutis-Morris; Cecilia Guillen-Vargas; Mario Salazar-Páramo; Diana E García-Cruz; Carlos Riebeling; Arnulfo Nava
Journal:  Rheumatol Int       Date:  2011-11-15       Impact factor: 2.631

2.  Adding fuel to the fire: methamphetamine enhances HIV infection.

Authors:  Raghava Potula; Yuri Persidsky
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

3.  Increased level of arginase activity correlates with disease severity in HIV-seropositive patients.

Authors:  T E Cloke; L Garvey; B-S Choi; T Abebe; A Hailu; M Hancock; U Kadolsky; C R M Bangham; M Munder; I Müller; G P Taylor; P Kropf
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

4.  Reduced T-cell receptor CD3zeta-chain protein and sustained CD3epsilon expression at the site of mycobacterial infection.

Authors:  U Seitzer; K Kayser; H Höhn; P Entzian; H H Wacker; S Ploetz; H D Flad; J Gerdes; M J Maeurer
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

5.  Low levels of NF-κB/p65 mark anergic CD4+ T cells and correlate with disease severity in sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Ali Kanchwala; Carter J H Childs; Yash P Kataria; Marc A Judson; Mark A Mazer; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

6.  Skin- and gut-homing molecules on human circulating γδ T cells and their dysregulation in inflammatory bowel disease.

Authors:  E R Mann; N E McCarthy; S T C Peake; A N Milestone; H O Al-Hassi; D Bernardo; C T Tee; J Landy; M C Pitcher; S A Cochrane; A L Hart; A J Stagg; S C Knight
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

7.  Effects of broad-spectrum antimycobacterial therapy on chronic pulmonary sarcoidosis.

Authors:  W P Drake; B W Richmond; K Oswald-Richter; C Yu; J M Isom; J A Worrell; G R Shipley
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2013-11-25       Impact factor: 0.670

8.  On cell signalling mechanism of Mycobacterium leprae soluble antigen (MLSA) in Jurkat T cells.

Authors:  Beenu Joshi; Sihem Khedouci; Pradeep Kumar Dagur; Aziz Hichami; Utpal Sengupta; Naim Akhtar Khan
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

9.  T cell CD3 receptor zeta (TCRzeta)-chain expression in children with idiopathic nephrotic syndrome.

Authors:  Diego H Aviles; Matti V Vehaskari; Kirk S Culotta; Jennifer Manning; Augusto C Ochoa; Arnold H Zea
Journal:  Pediatr Nephrol       Date:  2008-12-10       Impact factor: 3.714

10.  Covert operations: cancer's many subversive tactics in overcoming host defenses.

Authors:  Dan L Longo
Journal:  Trans Am Clin Climatol Assoc       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.